Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular (Wet) Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Large-scale testing (Phase 3)Looking for participantsNCT07482176
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 284
Not applicableEnded earlyNCT03699618
What this trial is testing

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Submacular HemorrhageWet Macular DegenerationNeovascular Age-related Macular Degeneration
Johns Hopkins University 1
Early research (Phase 1)WithdrawnNCT04919096
What this trial is testing

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Clover Biopharmaceuticals AUS Pty
Large-scale testing (Phase 3)Study completedNCT04516278
What this trial is testing

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 197
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178249
What this trial is testing

Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD

Who this might be right for
Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 60
Testing effectiveness (Phase 2)Study completedNCT00320788
What this trial is testing

Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 159
Testing effectiveness (Phase 2)Looking for participantsNCT05197270
What this trial is testing

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics 215
Large-scale testing (Phase 3)Study completedNCT01482910
What this trial is testing

VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)

Who this might be right for
Macular Degeneration
Bayer 304
Testing effectiveness (Phase 2)Ended earlyNCT00464347
What this trial is testing

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 100
Early research (Phase 1)Study completedNCT01024998
What this trial is testing

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationAge-Related MaculopathiesAge-Related Maculopathy+7 more
Genzyme, a Sanofi Company 19
Testing effectiveness (Phase 2)Ended earlyNCT01025232
What this trial is testing

Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more
David M. Brown, M.D. 88
Large-scale testing (Phase 3)Study completedNCT07389577
What this trial is testing

Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Jecho Biopharmaceuticals Co., Ltd. 443
Large-scale testing (Phase 3)Study completedNCT01436864
What this trial is testing

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 125
Not applicableUnknownNCT03944070
What this trial is testing

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Who this might be right for
Wet Macular DegenerationCataract Extraction
Ophthalmica Eye Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT01189019
What this trial is testing

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration

Who this might be right for
Wet Macular DegenerationMacular DegenerationRetinal Pigment Epithelial Detachment
Anne Fung MD 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05387837
What this trial is testing

Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 50
Large-scale testing (Phase 3)Study completedNCT01835067
What this trial is testing

Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD

Who this might be right for
Exudative Macular DegenerationRetinal Hemorrhage
King's College Hospital NHS Trust 55
Large-scale testing (Phase 3)Study completedNCT03834753
What this trial is testing

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 228
Next Page